Wondering how often to take AOD 9604? Learn typical research dosing schedules, timing, cycle length, and safety notes for this HGH fragment peptide.
Most people who use AOD 9604 inject 300 mcg once per day, usually in the morning on an empty stomach. Some protocols split that into two doses of 150 to 300 mcg, and a typical cycle runs 8 to 12 weeks before a break. There is no FDA-approved dosing schedule for AOD 9604 in humans, so every frequency you see online comes from research studies, vendor guidance, or user reports rather than official medical direction.
How Often to Take AOD 9604: Typical Schedules
The most common answer to how often do you take aod 9604 is once per day. AOD 9604, also called AOD-9604 or the HGH fragment 176-191, has a short reported half-life, which is the main reason some users split their dose across the day.
| Protocol style | Daily dose | Frequency | Common timing |
|---|---|---|---|
| Standard single dose | 300 mcg | Once daily | Morning, fasted |
| Split dose | 300 mcg total | Twice daily | Morning and pre-workout |
| Conservative start | 100–200 mcg | Once daily | Morning |
| Higher user dose | 500 mcg | Once or twice daily | Morning, fasted |
Doses above 500 mcg per day are not supported by published human trials. In the largest study of AOD 9604, participants received one injection per day for 12 weeks, and the weight-loss results were still not strong enough to win regulatory approval.
When to Take AOD 9604 Peptide: Timing and Fasting
The question of when to take aod 9604 peptide usually comes down to whether you train fasted and whether food affects absorption. Because AOD 9604 is a fragment of growth hormone rather than full HGH, it does not appear to raise IGF-1 or disrupt blood sugar the way some other peptides do.
- Morning, fasted: the most common choice — inject, wait 20 to 30 minutes, then eat.
- Before fasted cardio: some users time the dose about 30 minutes before morning training.
- Evening: less common, since AOD 9604 is not tied to natural growth hormone pulses the way GHRPs are.
No solid evidence shows that meal timing changes how well AOD 9604 works. Consistency matters more than hitting a perfect window every single day.
How to Use AOD 9604 Peptide: Injection and Storage Basics
Learning how to use aod 9604 peptide correctly starts with reconstitution, storage, and clean injection technique. AOD 9604 ships as a lyophilized powder that has to be mixed with bacteriostatic water before use.
- Swab both vial stoppers with alcohol and let them dry.
- Add bacteriostatic water slowly down the inside wall of the vial; do not shake it.
- Swirl gently until the powder dissolves completely.
- Refrigerate the reconstituted vial at 2–8°C and keep it away from light.
- Draw your dose with an insulin syringe and inject subcutaneously into the abdomen or thigh, rotating sites each time.
Many suppliers publish a how to reconstitute aod 9604 pdf alongside their vials, and those guides are worth reading because the concentration math changes with the volume of water you add. Label the vial with the date you mixed it, since reconstituted peptide is usually used within a few weeks.
How AOD 9604 Compares With Other Peptides
People comparing fat-loss and performance peptides usually want to know how the schedules differ. Users researching growth hormone secretagogues often ask how often to inject ipamorelin, which is typically dosed one to three times daily and timed around sleep rather than the morning.
| Peptide | Typical frequency | Research focus | Timing notes |
|---|---|---|---|
| AOD 9604 | 300 mcg once daily, sometimes split | Fat metabolism | Morning, fasted |
| Ipamorelin | 100–300 mcg, 1 to 3 times daily | Growth hormone release | Often before bed |
| Retatrutide | Once weekly | Obesity and type 2 diabetes (investigational) | Weekly injection, any time of day |
| PT-141 | As needed, not daily | Sexual health | Not a fat-loss peptide |
These compounds are not interchangeable. AOD 9604 is studied as an isolated fat-metabolism fragment, ipamorelin and similar peptides work by triggering growth hormone release, and retatrutide is a multi-receptor agonist still in clinical development.
Cycle Length, Breaks, and What the Evidence Shows
Most user protocols run 8 to 12 weeks on, followed by about 4 weeks off. Because there is no clinical guidance on cycling AOD 9604, those numbers come from community practice rather than trial data.
AOD 9604 is not FDA-approved for human use in the United States. The compound went through obesity trials in the 2000s but did not produce enough weight loss to earn approval, and it is now sold mainly as a research chemical or as an ingredient in topical cosmetic products.
That history should shape your expectations. AOD 9604 is not a replacement for a calorie deficit, resistance training, or medical treatment for obesity.
Safety and Side Effects
Reported side effects in trials were mild and included injection-site reactions, headache, and nausea. Because research chemicals sold online are not regulated for purity or sterility, the biggest practical risks are contamination and dosing errors.
Talk with a healthcare professional before using AOD 9604, especially if you are pregnant, nursing, taking prescription medication, or managing a chronic condition. Self-treating with unapproved peptides can delay care that is proven to work.
Frequently Asked Questions
How many times a day should you inject AOD 9604?
Most protocols use one injection of 300 mcg per day. Some users split the same total dose into two smaller injections, but there is no clinical evidence that splitting improves results. Because AOD 9604 is not FDA-approved for human use, no official dosing schedule exists.
Does AOD 9604 need to be taken on an empty stomach?
Most users inject AOD 9604 in the morning and wait 20 to 30 minutes before eating. That habit comes from growth hormone peptide protocols rather than from AOD 9604 research itself. No published study shows that food meaningfully changes how AOD 9604 behaves in the body.
Is AOD 9604 FDA-approved for weight loss?
No. AOD 9604 is not FDA-approved for weight loss or any other human use in the United States. It failed to produce enough weight loss in clinical trials to earn approval, and it is now sold primarily as a research chemical. Anyone seeking weight-loss treatment should speak with a healthcare professional about approved options.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.